Larvol Delta - FORWARD-Fibromyalgia-Response-With-Esreboxetine-Evaluated-Using-a-Randomized-Withdrawal-Research-Design

reboxetine (AXS-12) - Axsome Therap

esreboxetine (AXS-14) - Axsome Therap, Pfizer

http://clinicaltrials.gov/ct2/show/NCT07398417

Feb 10, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next